Saratoga Advantage · Technology Sector
Health & Biotechnology Portfolio: share classes compared
Health & Biotechnology Portfolio has 3 share classes. They hold the same portfolio — $10.5 million in total — but charge different fees and loads. The cheapest is SBHIX (Health & Biotechnology Portfolio Class I) at 2.6%.
| Ticker | Share class | Type | Expense ratio | Front load | 12b-1 | 1-yr | 5-yr | 10-yr |
|---|---|---|---|---|---|---|---|---|
| SHPAX | Health & Biotechnology Portfolio Class A | Mutual fund | 3% | 5.75% | — | −5.5% | +3.1% | +4.1% |
| SBHIX | Health & Biotechnology Portfolio Class I | Mutual fund | 2.6% | 0% | — | +0.7% | +4.7% | +5.2% |
| SHPCX | Health & Biotechnology Porfolio Class C | Mutual fund | 3.6% | 0% | — | −1.3% | +3.7% | +4.1% |
Source: Fund prospectus, filed Dec 29, 2025
Objective
The Health & Biotechnology Portfolio seeks long-term capital growth.
Top holdings
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%